Kazuyuki Sugishita

Optimising first- and second-line treatment strategies for untreated major depressive disorder — the SUN☺D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial

G. Guyatt, Y. Okamoto, T. Furukawa, 2018, BMC Medicine.

Expression of Costimulatory Molecules (4-1BBL and Fas) and Major Histocompatibility Class I Chain-Related A (MICA) in Aortic Tissue with Takayasu’s Arteritis

Y. Seko, R. Nagai, K. Okumura, 2004, Journal of Vascular Research.

Continuous positive airway pressure for obstructive sleep apnea improved negative symptoms in a patient with schizophrenia

H. Yamasue, K. Kasai, Kazuyuki Sugishita, 2010, Psychiatry and Clinical Neurosciences.

Acute psychosis during the postictal period in a patient with idiopathic generalized epilepsy: Postictal psychosis or aggravation of schizophrenia? A case report and review of the literature

K. Kasai, Y. Inoue, Eisuke Sakakibara, 2012, Epilepsy & Behavior.

Betaine supplementation improves positive symptoms in schizophrenia

K. Kasai, M. Itokawa, Taiga Hosokawa, 2022, Schizophrenia Research.

Whose depression deteriorates during acute phase antidepressant treatment?

T. Furukawa, N. Yonemoto, Y. Ogawa, 2019, Journal of affective disorders.

A Validity and Reliability Study of the Japanese Version of the Geriatric Depression Scale 15 (GDS-15-J)

T. Asada, M. Sugishita, T. Tanigawa, 2017, Clinical Gerontologist.